Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, non-randomized, controlled clinical trial

被引:1
|
作者
Li, Xiangjun [1 ]
Li, Chunyan [2 ]
Huang, Hai [2 ]
Bai, Dan [1 ]
Wang, Jingyi [1 ]
Chen, Anqi [2 ]
Gong, Yu [2 ]
Leng, Ying [1 ]
机构
[1] Beihua Univ, Affiliated Hosp, Dept Ophthalmol, Jilin, Jilin, Peoples R China
[2] Beihua Univ, Affiliated Hosp, Dept Endocrinol, Jilin, Jilin, Peoples R China
关键词
choroidal thickness; diabetic macular edema; laser photocoagulation; retinal ganglion cell-inner plexiform layer thickness; retinal ganglion cells; retinal nerve fiber layer thickness; thickness of the macular area; vascular endothelial growth factor; visual acuity; VISUAL FUNCTION; RETINOPATHY; CONBERCEPT;
D O I
10.4103/1673-5374.382104
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The integrity of retinal ganglion cells is tightly associated with diabetic macular degeneration that leads to damage and death of retinal ganglion cells, affecting vision. The major clinical treatments for diabetic macular edema are anti-vascular endothelial growth factor drugs and laser photocoagulation. However, although the macular thickness can be normalized with each of these two therapies used alone, the vision does not improve in many patients. This might result from the incomplete recovery of retinal ganglion cell injury. Therefore, a prospective, non-randomized, controlled clinical trial was designed to investigate the effect of anti-vascular endothelial growth factor drugs combined with laser photocoagulation on the integrity of retinal ganglion cells in patients with diabetic macular edema and its relationship with vision recovery. In this trial, 150 patients with diabetic macular edema will be equally divided into three groups according to therapeutic methods, followed by treatment with anti-vascular endothelial growth factor drugs, laser photocoagulation therapy, and their combination. All patients will be followed up for 12 months. The primary outcome measure is retinal ganglion cell-inner plexiform layer thickness at 12 months after treatment. The secondary outcome measures include retinal ganglion cell-inner plexiform layer thickness before and 1, 3, 6, and 9 months after treatment, retinal nerve fiber layer thickness, best-corrected visual acuity, macular area thickness, and choroidal thickness before and 1, 3, 6, 9, and 12 months after treatment. Safety measure is the incidence of adverse events at 1, 3, 6, 9, and 12 months after treatment. The study protocol hopes to validate the better efficacy and safety of the combined treatment in patients with diabetic macula compared with the other two monotherapies alone during the 12-month follow-up period. The trial is designed to focus on clarifying the time-effect relationship between imaging measures related to the integrity of retinal ganglion cells and best-corrected visual acuity. The trial protocol was approved by the Medical Ethics Committee of the Affiliated Hospital of Beihua University with approval No. (2023)(26) on April 25, 2023, and was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2300072478, June 14, 2023, protocol version: 2.0).
引用
收藏
页码:923 / 928
页数:6
相关论文
共 50 条
  • [1] Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema:study protocol for a prospective,non-randomized,controlled clinical trial
    Xiangjun Li
    Chunyan Li
    Hai Huang
    Dan Bai
    Jingyi Wang
    Anqi Chen
    Yu Gong
    Ying Leng
    Neural Regeneration Research, 2024, 19 (04) : 923 - 928
  • [2] Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
    Li, Yun-Fei
    Ren, Qian
    Sun, Chao-Hui
    Li, Li
    Lian, Hai-Dong
    Sun, Rui-Xue
    Su, Xian
    Yu, Hua
    WORLD JOURNAL OF DIABETES, 2022, 13 (07) : 532 - 542
  • [3] Visual and Anatomic Outcomes of Combined Focal Navigated Laser Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema
    Miller, Randee C.
    Yashraj, Chandan
    Jager, Rama
    Bhatt, Harit
    Sheth, Veeral
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [4] Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis
    Chen, Jiasheng
    Wang, Haowei
    Qiu, Weiqiang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial
    Kanar, Hatice Selen
    Arsan, Aysu
    Altun, Ahmet
    Aki, Suat Fazil
    Hacisalihoglu, Aynur
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (01) : 145 - +
  • [6] Combination therapy with subthreshold diode laser micropulse photocoagulation and intravitreal anti-vascular endothelial growth factor injections for diabetic macular edema
    Thinda, Sumeer
    Patel, Amar P.
    Hunter, Allan A.
    Moshiri, Ala
    Morse, Lawrence S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] Combined intravitreal anti-vascular endothelial growth factor and grid macular laser for macular edema due to branch retinal vein occlusion
    Bharucha, Grishma
    Braich, Puneet Singh
    Brar, Vikram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial
    Jampol, Lee M.
    Glassman, Adam R.
    Bressler, Neil M.
    Wells, John A.
    Ayala, Allison R.
    JAMA OPHTHALMOLOGY, 2016, 134 (12) : 1429 - 1434
  • [9] Nondamaging focal retinal laser therapy for the treatment of diabetic macular edema reduces anti-vascular endothelial growth factor injection burden
    Durrani, Asad Farooq
    Paulus, Yannis Mantas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [10] Clinical Practice Patterns of Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Treatment of Patients with Diabetic Macular Edema: A Retrospective Study
    Safdar, Nida
    Ali, Amir
    Tanwani, Anika
    Karimaghaei, Cina
    Polychronopoulou, Efstathia
    Schmitz-Brown, Mary
    El-Annan, Jaafar
    Gupta, Praveena
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)